S Telimaa
No ORCID on file
· 10 papers in corpus
· active 1987-1991
Study types
- article 8
- other 2
Condition tags
- endometriosis 10
- infertility 3
Top journals
- Fertility and Sterility 3
- Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2
- Acta obstetricia et gynecologica Scandinavica 1
- American Journal of Obstetrics and Gynecology 1
- European journal of obstetrics, gynecology, and reproductive biology 1
Frequent coauthors
- Lars Rönnberg 9
- Antti Kauppila 8
- Jukka Puolakka 3
- I Penttila 2
- Dan Apter 1
- F Nordenskiöld 1
- J Vuori 1
- M Reinilä 1
- M Seppälä 1
- Markku Seppällä 1
article
1991
article
1990
article
1990
other
1989
In a study on endometriosis, ten patients were treated with danazol (200 mg three times a day) and ten patients with high-dose medroxyprogesterone acetate (MPA) (100 mg a day) for 6 months. The circulating high-density lipoprotein-cholester…
article
1989
article
1989
Progestins, including medroxyprogesterone acetate (MPA), danazol and gestrinone, are used in the medical management of endometriosis. Danazol and gestrinone, by inducing progestin-like effects, closely resemble MPA in their actions on intra…
article
1988
other
1988
Serum concentrations of CA-125 were determined in association with 6-month medical (n = 48) or surgical and medical therapy (n = 40) of endometriosis. The concentration of CA-125 was significantly higher in stages III + IV (66.6 +/- 22.0 [s…
article
1987
A prospective, double-blind, placebo-controlled study was designed to evaluate the clinical efficacy and tolerance of danazol and high-dose medroxyprogesterone acetate (MPA) in the treatment of mild-moderate endometriosis. After laparoscopi…
article
1987
To evaluate the clinical value of postoperative hormone therapy in endometriosis, 60 patients with advanced disease were randomized to receive in a double-blind study danazol (200 mg, 3 times daily), medroxyprogesterone acetate (MPA) (100 m…